AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Regulatory Filings Feb 9, 2016

4924_rns_2016-02-09_384e4582-a4a3-4365-8080-a0de1d28339c.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4401O

Assura PLC

09 February 2016

9 February 2016

Assura plc

Statement regarding Chief Executive, Graham Roberts 

The Board of Assura plc announces that its Chief Executive, Graham Roberts, has been diagnosed with cancer. He continues to receive treatment and remains actively involved in running the business. 

Simon Laffin, Chairman said: "We have a clear strategy, and Graham is well-supported in delivering this by the first-class management team that he has developed. I shall be available to provide executive oversight if required. We all wish Graham well in his treatment and recovery."

-ENDS-

For more information, please contact:

Assura plc Tel: 01925 420660
Jonathan Murphy
Finsbury Tel: 0207 251 3801
Gordon Simpson

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. It owns 305 medical centres nationwide, serving over 3 million patients. At 30 September 2015, Assura's property portfolio was valued at £1,030 million.

Further information is available at www.assuraplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCTPMRTMBAMBRF

Talk to a Data Expert

Have a question? We'll get back to you promptly.